The new drug, Imraldi, marks the third European Commission approval for “biosimilar” versions from the joint venture, Samsung Bioepis, of drugs in a class known as TNF inhibitors.
Samsung, Biogen version of AbbVie’s Humira approved in Europe

The new drug, Imraldi, marks the third European Commission approval for “biosimilar” versions from the joint venture, Samsung Bioepis, of drugs in a class known as TNF inhibitors.
CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia – Oncodesign is expanding its service offering in immunology and infectious diseases
Sandoz, a Novartis division, recently announced that The Canadian Drug Expert Committee (CDEC) as part of the Common Drug Review (CDR) process has issued a positive drug reimbursement recommendation for Erelzi (etanercept). Health Canada granted Erelzi a Notice of Compliance in April 2017.
Anesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices (Ventilators, Nebulizers, Oxygen Therapy Devices and Disposables) & Sleep Management Devices (Therapeutic OSA and Sleep Diagnostic Devices)
Anesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices (Ventilators, Nebulizers, Oxygen Therapy Devices and Disposables) & Sleep Management Devices (Therapeutic OSA and Sleep Diagnostic Devices)
Anesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices (Ventilators, Nebulizers, Oxygen Therapy Devices and Disposables) & Sleep Management Devices (Therapeutic OSA and Sleep Diagnostic Devices)
Anesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Anesthesia Devices (Disposables, Monitors, Delivery Units), Respiratory Devices (Ventilators, Nebulizers, Oxygen Therapy Devices and Disposables) & Sleep Management Devices (Therapeutic OSA and Sleep Diagnostic Devices)